Earnings calls

Nath Bio-Genes concall ledger

Every earnings call for NATHBIOGEN — management tone, guidance, KPIs and promise tracking, quarter by quarter.

NATHBIOGEN · 3 transcripts · Fast Moving Consumer Goods · latest Q4 FY26

Q4 FY26Published 05 May 2026Call held 05 May 2026

NATHBIOGEN Q4 FY26 Earnings Call Transcript & Analysis

Revenue4,316 million+19% YoYEBITDA525 millionEBITDA Margin12%PAT384 million−8% YoYPAT Margin9%

Revenue 4316 million (+19% YoY); EBITDA 525 million; EBITDA Margin 12%. Total revenue grew 19% YoY to INR 4,316 million in FY26.

Read full transcript & analysis

Q2 FY26Published 14 Nov 2025Call held 14 Nov 2025

NATHBIOGEN Q2 FY26 Earnings Call Transcript & Analysis

Revenue3,199 million+16% YoYPAT424 million+15% YoY

Revenue 3199 million (+16% YoY); PAT 424 million (+15% YoY). H1 FY26 Revenue grew 15.9% YoY to INR3,199 million.

Read full transcript & analysis

Q4 FY25Published 30 Apr 2025Call held 30 Apr 2025

NATHBIOGEN Q4 FY25 Earnings Call Transcript & Analysis

Revenue₹362.3 cr+9% YoYEBITDA₹52 cr+4% YoYPAT₹41.6 cr+13% YoYGross Margin52%

Revenue ₹362 cr (+9% YoY); EBITDA ₹52 cr (+4% YoY); PAT ₹42 cr (+13% YoY). Total revenue for FY25 stood at INR362.30 crores, with top line growth around 9% YoY.

Read full transcript & analysis